BioCentury
ARTICLE | Product Development

BARDA takes steps to secure supply chain as more companies look to scale up manufacturing

HHS agency closes $354M deal to manufacture APIs in the U.S.; plus updates from Dynavax, Abivax, NantKwest

May 20, 2020 12:31 AM UTC

HHS is taking steps to shore up the U.S.’s national supply chain and manufacturing capabilities after global disruptions in the early days of the COVID-19 crisis. The agency’s BARDA has closed a four-year, $354 million deal with Phlow Corp. to manufacture medicines needed during the pandemic and future public health emergencies.

Manufacturing continues to be a rate-limiting factor for COVID-19 countermeasures. Abivax S.A. (Euronext:ABVX) and NantKwest Inc. (NASDAQ:NK) have secured funding and materials to scale up manufacturing for their therapies as they near the clinic. Dynavax expects clinical testing to begin in July for a vaccine developed with its adjuvant. ...



Access The Full Article